statistiche ricercatore

ANGELI, FABIO

Distribuzione geografica

Continente	#
NA - Nord America	14.575
EU - Europa	10.044
AS - Asia	1.248
SA - Sud America	11
AF - Africa	5
Continente sconosciuto - Info sul continente non disponibili	4
OC - Oceania	2
Totale	25.889

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	14.553
IT - Italia	6.246
UA - Ucraina	1.667
IE - Irlanda	749
VN - Vietnam	641
DE - Germania	549
SE - Svezia	369
GB - Regno Unito	322
SG - Singapore	245
CN - Cina	213
TR - Turchia	56
FI - Finlandia	48
JP - Giappone	47
FR - Francia	26
IN - India	21
CA - Canada	12
AT - Austria	11
CZ - Repubblica Ceca	11
CH - Svizzera	9
TT - Trinidad e Tobago	8
PK - Pakistan	7
RU - Federazione Russa	7
BR - Brasile	6
NL - Olanda	6
RO - Romania	5
BE - Belgio	4
EU - Europa	4
ES - Italia	3
GR - Grecia	3
KE - Kenya	3
AU - Australia	2
IL - Israele	2
KR - Corea	2
MY - Malesia	2
PE - Perù	2
PH - Filippine	2
RS - Serbia	2
TW - Taiwan	2
AM - Armenia	1
BG - Bulgaria	1
CL - Cile	1
CO - Colombia	1
EC - Ecuador	1
EE - Estonia	1
EG - Egitto	1
HK - Hong Kong	1
HR - Croazia	1
ID - Indonesia	1
IQ - Iraq	1
KZ - Kazakistan	1
LK - Sri Lanka	1
LT - Lituania	1
LU - Lussemburgo	1
MX - Messico	1
OM - Oman	1
PA - Panama	1
SA - Arabia Saudita	1
SI - Slovenia	1
SK - Slovacchia (Repubblica Slovacca)	1
ZA - Sudafrica	1
Totale	25.889

Salva come PNG Salva come JPEG

Città	#
Milan	4.668
Fairfield	2.751
Ashburn	1.815
Woodbridge	1.298
Seattle	1.098
Wilmington	1.034
Houston	1.023
Cambridge	938
Jacksonville	885
Dublin	735
Princeton	650
Rome	447
Boardman	430
Ann Arbor	404
Chandler	397
Dong Ket	330
Singapore	240
Nyköping	233
San Diego	221
Washington	200
Ogden	136
Beijing	92
London	87
New York	76
Kocaeli	53
Santa Clara	53
Chicago	46
Tokyo	46
Helsinki	39
Los Angeles	25
Como	23
Norwalk	23
Prescot	23
Kilburn	19
Dallas	17
Redmond	17
Treviglio	17
Munich	16
Kunming	14
Chiswick	13
Redwood City	12
Acton	11
Hefei	11
Shanghai	11
Vienna	11
Brno	10
Hounslow	10
Nanjing	10
Southwark	10
Wandsworth	10
Chennai	9
Varese	9
Chaguanas	8
Olgiate Comasco	8
Lappeenranta	7
Toronto	7
Bergamo	6
Jinan	6
Menlo Park	6
New Bedfont	6
Pune	6
Turin	6
Zhengzhou	6
Guangzhou	5
Magnago	5
Nanchang	5
San Genesio Ed Uniti	5
Amsterdam	4
Assago	4
Bassano del Grappa	4
Beauharnois	4
Brussels	4
Frankfurt am Main	4
Hebei	4
Leawood	4
Paris	4
San Francisco	4
Shenyang	4
Stockholm	4
São Paulo	4
Wuhan	4
Xian	4
Zurich	4
Alleppey	3
Bern	3
Busto Arsizio	3
Chengdu	3
Esslingen am Neckar	3
Ferentino	3
Fuzhou	3
Greenwich	3
Lesmo	3
Phoenix	3
Athens	2
Atlanta	2
Belgrade	2
Berlin	2
Buffalo	2
Catania	2
Chongqing	2
Totale	20.956

Salva come PNG Salva come JPEG

Nome	#
Response to Is Vascular Morning Blood Pressure Surge in the Elderly Resistant to Antihypertensives and More Risky?	203
How can we use the results of ambulatory blood pressure monitoring in clinical practice?	181
Optimal Therapy in Hypertensive Subjects with Diabetes Mellitus	172
Circadian rhythm of pulse pressure in hypertension: Prognostic implications	167
Association between periodontal disease and left ventricle mass in essential hypertension	164
Simplifying the ECG Diagnosis of Left Ventricular Hypertrophy	156
Good news for beta-blockers in perioperative medicine	140
Microcirculation and left-ventricular hypertrophy	134
Exploring the optimal combination therapy in hypertensive patients with diabetes mellitus	133
Intensive Blood Pressure Lowering and Regression of Left Ventricular Hypertrophy	129
DAY-NIGHT RELATED EVENTS: NIGHTTIME BLOOD PRESSURE FALL AND MORNING BLOOD PRESSURE RISE	125
Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and protection from stroke	123
Sudden Cardiac Death in Hypertensive Patients	121
Above Which Blood Pressure Level Does the Risk of Atrial Fibrillation Increase?	119
Dabigatran vs. warfarin in relation to the presence of left ventricular hypertrophy in patients with atrial fibrillation-the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) study	118
Safety and efficacy of aliskiren in the treatment of hypertension: a systematic overview	115
Aggressive blood pressure reduction in patients at high vascular risk: Is it dangerous?	114
Modernization and hypertension: is the link changing?	114
Hypertension and the J-curve phenomenon: implications for tight blood pressure control	113
Interpretation of Ambulatory Blood Pressure Profile for Risk Stratification Keep It Simple	112
The clinical significance of white-coat and masked hypertension	111
Amlodipine and celecoxib for treatment of hypertension and osteoarthritis pain	111
Adverse prognostic significance of new diabetes in treated hypertensive subjects	111
The optimal blood pressure target for patients with coronary artery disease	111
Long-term outcome in patients with non-valvular atrial fibrillation on dabigatran: a prospective cohort study	110
At the beginning of stiffening - Endothelial dysfunction meets "pulsology"	110
PK/PD evaluation of fimasartan for the treatment of hypertension Current evidences and future perspectives	110
Cardiac Benefits of an Intensive Blood Pressure Control in Diabetes Mellitus	109
Aggressive Blood Pressure Lowering Is Dangerous: The J-Curve Con Side of the Argument	109
How important is to reduce sodium and increase potassium in patients with hypertension?	108
Neutrophil Count for the Identification of Postmenopausal Hypertensive Women at Increased Cardiovascular Risk	108
Does brachial pulse pressure predict coronary events?	107
Ambulatory blood pressure monitoring and prognosis in the management of essential hypertension	107
Very early initiation of statin therapy and mortality in patients with acute coronary syndrome	106
Echocardiographic left ventricular hypertrophy in hypertension: marker for future events or mediator of events?	105
Pulse pressure affects the relationship between flow-mediated dilatation and cardiovascular risk	105
Ambulatory blood pressure for cardiovascular risk stratification	105
Detrimental Effects of Hyperglycemia in Acute Coronary Syndromes: from Pathophysiological Mechanisms to Therapeutic Strategies	105
A Risk Score for Predicting 1-Year Mortality in Patients >= 75 Years of Age Presenting With Non-ST-Elevation Acute Coronary Syndrome	105
Atrial fibrillation in hypertension - Predictors and outcome	103
White-coat hypertension in adults	103
What to Do When Blood Pressure Is Between 130/80 and 139/89 mm Hg?	103
Aliskiren versus ramipril in hypertension	103
Impact of blood pressure variability on cardiac and cerebrovascular complications in hypertension	103
Hyperglycemia in acute coronary syndromes: From mechanisms to prognostic implications	103
Response to Role of Yin and Yang in Diurnal Blood Pressure Variation for Cardiovascular Disease	102
Is Hydrochlorothiazide More Effective on LVH in Nonresponders to Losartan Than in Those to Atenolol?	102
Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis	102
Improved cardiovascular risk stratification by a simple ECG index in hypertension	102
Angiotensin-converting enzyme inhibitors	101
Estimate of white-coat effect and arterial stiffness	101
Early Invasive Versus Selectively Invasive Strategy in Patients With Non-ST- Segment Elevation Acute Coronary Syndrome: Impact of Age	101
The emerging role of high-density lipoprotein cholesterol in hypertension trials	101
Risk of cardiovascular disease in relation to achieved office and ambulatory blood pressure control in treated hypertensive subjects	100
Electrocardiographic abnormalities of left ventricular repolarization: Prognostic implications in hypertensive post-menopausal women	100
Day-Night Dip and Early-Morning Surge in Blood Pressure in Hypertension Prognostic Implications	99
Prognostic value of serial Electrocardiographic voltage and repolarization changes in essential hypertension: The HEART survey study	99
Day-to-day variability of electrocardiographic diagnosis of left ventricular hypertrophy in hypertensive patients. Influence of electrode placement	99
Left Ventricular Hypertrophy and Coronary Artery Calcifications: A Dangerous Duet?	98
Hypertension, inflammation and atrial fibrillation	98
Neutrophil Count and Ambulatory Pulse Pressure as Predictors of Cardiovascular Adverse Events in Postmenopausal Women with Hypertension	98
Additive value of standard ECG for the risk prediction of hypertensive disorders during pregnancy	98
Risk of stroke in white-coat hypertension: A multinational registry	98
Atrial Fibrillation and Mortality in Patients with Acute Myocardial Infarction: A Systematic Overview and Meta-analysis	97
Compared with whom? Addressing the prognostic value of ambulatory blood pressure categories	97
Blood pressure lowering in diabetic patients	97
Atrial activation analysis by surface P wave and multipolar esophageal recording after cardioversion of persistent atrial fibrillation	97
The voltage of R wave in lead aVL improves risk stratification in hypertensive patients without ECG left ventricular hypertrophy	96
Safety and efficacy of aliskiren in the treatment of hypertension and associated clinical conditions	96
Meta-analysis of effectiveness or lack thereof of angiotensin-converting enzyme inhibitors for prevention of heart failure in patients with systemic hypertension	96
Short- and long-term incidence of stroke in white-coat hypertension	96
Finding a place for aliskiren in the wide spectrum of blood pressure lowering agents	96
New-onset diabetes, antihypertensive treatment, and outcome	96
Assessment of the optimal daily dose of valsartan in patients with hypertension, heart failure, or both	95
Natural history of hypertension subtypes	95
Clinical significance of the blood pressure changes from day to night	95
Does the reduction in systolic blood pressure alone explain the regression of left ventricular hypertrophy?	95
European and US guidelines for arterial hypertension: similarities and differences	95
Do angiotensin II receptor blockers increase the risk of myocardial infarction?	95
Safety and efficacy of non-vitamin K oral anticoagulants in non-valvular atrial fibrillation: a Bayesian meta-analysis approach	95
Renal dysfunction, coronary revascularization and mortality among elderly patients with non ST elevation acute coronary syndrome	94
Pharmacokinetic, pharmacodynamic and clinical evaluation of aliskiren for hypertension treatment	94
Validation of the A&D UA-705 device for self-measurement of blood pressure according to the British Hypertension Society protocol	94
Influence of blood pressure reduction on composite cardiovascular endpoints in clinical trials	94
Angiotensin-converting enzyme inhibitors and calcium channel blockers for coronary heart disease and stroke prevention	94
Asymptomatic left ventricular systolic dysfunction in essential hypertension - Prevalence, determinants, and prognostic value	94
New-onset diabetes in treated hypertensive patients	94
Blood pressure reduction and renin-angiotensin system inhibition for prevention of congestive heart failure: a meta-analysis	93
Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials	93
The Evolution and Refinement of Traditional Risk Factors for Cardiovascular Disease	93
Adverse prognostic significance of new diabetes in treated hypertensive subjects	93
Prognostic value of lipoprotein fractions in essential hypertension	93
Tight Blood Pressure Control in Diabetes: Evidence-Based Review of Treatment Targets in Patients with Diabetes	93
PROGNOSTIC VALUE OF URIC ACID IN RELATION TO DIFFERENT AMBULATORY BLOOD PRESSURE COMPONENTS IN THE ABP-INTERNATIONAL STUDY	92
Effects of barnidipine on blood pressure and left ventricular diastolic function in patients with hypertension and metabolic syndrome: A 12-week, open-label noncomparison study	92
Circadian rhythm of pulse pressure in hypertension: Prognostic implications	92
Changes in cardiovascular risk by reduction of left ventricular mass in hypertension: A meta-analysis	92
Clinical usefulness of ambulatory blood pressure monitoring	92
Improved performance of traditional ECG for diagnosis of left ventricular hypertrophy in hypertension	92
Diuretic Treatment of Hypertension	92
Totale	10.712

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	129.211
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	129.211

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2019/2020	5.188	0	0	0	0	0	678	1.282	1.082	820	558	195	573
2020/2021	7.218	55	1.246	354	937	206	1.072	268	640	728	401	421	890
2021/2022	2.848	271	509	61	89	82	120	183	221	193	444	309	366
2022/2023	2.025	341	75	82	146	91	513	15	232	248	169	58	55
2023/2024	7.948	1.109	1.235	1.191	1.477	1.746	769	46	61	200	39	11	64
2024/2025	1.142	15	41	932	83	71	0	0	0	0	0	0	0
Totale													26.369